First slide

The world’s science and technology leader Merck, announced its investment in a neuromorphic computing startup SynSense, based in China and Switzerland. The deal will boost Merck’s presence in Chinese artificial intelligence market.

The artificial intelligence startup SynSense provides an unprecedented combination of ultra-low power consumption and low latency for a broad range of edge applications in smart home, smart security, autonomous driving, drones or robots.

The prominent acquisitions and investments by Merck are featured below:

  • January 2020: Merck, had announced an investment of $275 million for a new Biotech Development Center in Switzerland. The new facility will be located in Corsier-sur-Vevey, Switzerland. Merck’s new center will be devoted to biotech development and manufacturing for clinical studies.

This R&D investment by the company will help secure capacity and high agility to deliver clinical trial material cost-effectively. The development center will contribute to accelerate the timelines for new biological entities, and address the increasing manufacturing complexity of the next generations of biotech compounds.

October 2019: Merck completed the acquisition of Versum Materials, Inc. for approximately $6.4 billion. The acquisition is expected to make Merck a leading electronic materials player focused on the semiconductor and display industries. The combination will increase the number of Merck employees by approximately 2,300 to a total of around 56,000 in 66 countries of the world.

  • October 2019: Merck, announced the expansion of its pigments production. The company expanded its global production capacities and optimized its manufacturing processes for effect pigments. The new facilities at the Gernsheim will significantly increase the production of silicon dioxide flakes, a special substrate for a whole range of unique effect pigments. The Gernsheim site is Merck’s largest pigment production facility worldwide.
  • Sept 2019: Merck completed the acquisition of California-based Intermolecular, Inc, an advanced materials innovator. The acquisition strengthens Merck as a strong solutions provider in the electronic materials industry positioned to drive the development of next-generation digital devices and technologies.

About Merck KGaA
Merck KGaA is a German science and technology company operating in various sectors such as healthcare, life science, and performance materials. The company was started in 1668, and now has approximately 56,000 employees across the world. It has global rights to use the Merck name and brand. The only exceptions are the USA and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.

Prominent Global Investors

View all

Related News